Evidence for the efficacy and safety of tolterodine in the treatment of overactive bladder.
about
Combined use of alpha-adrenergic and muscarinic antagonists for the treatment of voiding dysfunction.Regulation of bladder muscarinic receptor subtypes by experimental pathologiesTolterodine for the treatment of overactive bladder: a review.Trospium chloride: an anticholinergic quaternary ammonium compound for the treatment of overactive bladder.Blood-brain barrier permeation and efflux exclusion of anticholinergics used in the treatment of overactive bladder.Pharmacokinetics and toxicity of antimuscarinic drugs for overactive bladder treatment in females.Tolterodine for the treatment of urge urinary incontinence.Characterization of bladder selectivity of antimuscarinic agents on the basis of in vivo drug-receptor binding.A prospective observational study of the effects of treatment with extended-release tolterodine on health-related quality of life of patients suffering overactive bladder syndrome in Sweden.Low-Dose Anticholinergic Combination Therapy in Male Benign Prostatic Hyperplasia Patients with Overactive Bladder Symptoms.
P2860
Q33224958-EBEBC6E7-D6AE-4C29-A52F-8672CE1B102FQ35745805-364140C4-D4F6-44EE-A7FA-64D36026CACEQ36150735-10B99E43-20A8-42E2-ABFB-C08F6C88CF19Q36192782-2ED04A2D-ABAD-45CD-9C04-9906433A98B3Q37990531-ACD8B660-62F7-49E2-8578-5272CDD330F0Q38032608-F7654E4D-B5B1-4F0F-858B-D307DDFDC5FFQ38124056-E15028C9-78A6-4EBD-B635-D12F3B7D8EA1Q42428489-A2157D33-8F36-4FBD-90B4-88B5C7748E41Q43109559-1A794FCE-9028-4D6D-9EDA-7641BEA5BC4EQ53386633-A6586313-A275-4B20-922E-EAD7DB6697DE
P2860
Evidence for the efficacy and safety of tolterodine in the treatment of overactive bladder.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Evidence for the efficacy and ...... eatment of overactive bladder.
@ast
Evidence for the efficacy and ...... eatment of overactive bladder.
@en
Evidence for the efficacy and ...... eatment of overactive bladder.
@nl
type
label
Evidence for the efficacy and ...... eatment of overactive bladder.
@ast
Evidence for the efficacy and ...... eatment of overactive bladder.
@en
Evidence for the efficacy and ...... eatment of overactive bladder.
@nl
prefLabel
Evidence for the efficacy and ...... eatment of overactive bladder.
@ast
Evidence for the efficacy and ...... eatment of overactive bladder.
@en
Evidence for the efficacy and ...... eatment of overactive bladder.
@nl
P2860
P1476
Evidence for the efficacy and ...... eatment of overactive bladder.
@en
P2093
P2860
P304
P356
10.1517/14656566.2.10.1685
P407
P577
2001-10-01T00:00:00Z